Squamous cell carcinoma of the prostate: long-term survival after combined chemo-radiation

Fernando Muñoz(Azienda Ospedaliero Universitaria San Giovanni Battista), Umberto Ricardi(Azienda Ospedaliero Universitaria San Giovanni Battista), Pierfrancesco Franco(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Patrizia Ciammella(Azienda Sanitaria Unità Locale di Reggio Emilia), Mario Clerico(Ospedale degli Infermi), Mauro Giudici(Azienda Ospedaliera G. Brotzu), Andrea Riccardo Filippi(University of Turin)
Radiation Oncology
May 2, 2007
10.1186/1748-717x-2-15
Cited by 37

Related Papers

Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
|The Lancet Oncology|2020|1.1k
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|Radiotherapy and Oncology|2020|646
An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung Cancer
|Clinical Lung Cancer|2014|437
SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease
|Neuro-Oncology|2013|371
Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial
|Lung Cancer|2009|277